Literature DB >> 19652197

Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model.

Xiaoxia Hu1, Hongmei Shen, Chen Tian, Hui Yu, Guoguang Zheng, Richard XuFeng, Zhenyu Ju, Jing Xu, Jianmin Wang, Tao Cheng.   

Abstract

The predominant outgrowth of malignant cells over their normal counterparts in a given tissue is a shared feature for all types of cancer. However, the impact of a cancer environment on normal tissue stem and progenitor cells has not been thoroughly investigated. We began to address this important issue by studying the kinetics and functions of hematopoietic stem and progenitor cells in mice with Notch1-induced leukemia. Although hematopoiesis was progressively suppressed during leukemia development, the leukemic environment imposed distinct effects on hematopoietic stem and progenitor cells, thereby resulting in different outcomes. The normal hematopoietic stem cells in leukemic mice were kept in a more quiescent state but remained highly functional on transplantation to nonleukemic recipients. In contrast, the normal hematopoietic progenitor cells in leukemic mice demonstrated accelerated proliferation and exhaustion. Subsequent analyses on multiple cell-cycle parameters and known regulators (such as p21, p27, and p18) further support this paradigm. Therefore, our current study provides definitive evidence and plausible underlying mechanisms for hematopoietic disruption but reversible inhibition of normal hematopoietic stem cells in a leukemic environment. It may also have important implications for cancer prevention and treatment in general.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652197      PMCID: PMC2773494          DOI: 10.1182/blood-2009-06-227843

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome.

Authors:  Sebastian Stier; Tao Cheng; David Dombkowski; Nadia Carlesso; David T Scadden
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

Review 2.  Cell cycle inhibitors in normal and tumor stem cells.

Authors:  Tao Cheng
Journal:  Oncogene       Date:  2004-09-20       Impact factor: 9.867

3.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

Review 4.  Enrichment of murine haemopoietic stem cells: diverging roads.

Authors:  G J Spangrude
Journal:  Immunol Today       Date:  1989-10

5.  Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle.

Authors:  A Gothot; R Pyatt; J McMahel; S Rice; E F Srour
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

6.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

7.  Competitive repopulation: a new assay for long-term stem cell functional capacity.

Authors:  D E Harrison
Journal:  Blood       Date:  1980-01       Impact factor: 22.113

8.  Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells.

Authors:  Hanno Hock; Melanie J Hamblen; Heather M Rooke; Jeffrey W Schindler; Shireen Saleque; Yuko Fujiwara; Stuart H Orkin
Journal:  Nature       Date:  2004-09-29       Impact factor: 49.962

9.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.

Authors:  W S Pear; J C Aster; M L Scott; R P Hasserjian; B Soffer; J Sklar; D Baltimore
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

10.  Asymmetric division and lineage commitment at the level of hematopoietic stem cells: inference from differentiation in daughter cell and granddaughter cell pairs.

Authors:  Hina Takano; Hideo Ema; Kazuhiro Sudo; Hiromitsu Nakauchi
Journal:  J Exp Med       Date:  2004-01-26       Impact factor: 14.307

View more
  21 in total

1.  MLL-ENL leukemia burden initiated in femoral diaphysis and preceded by mature B-cell depletion.

Authors:  Agnieszka Jaracz-Ros; Daniel Lewandowski; Vilma Barroca; Catherine Lavau; Paul-Henri Roméo
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  Hematopoiesis in patients with mature B-cell malignancies is deregulated even in patients with undetectable bone marrow involvement.

Authors:  Bokang Calvin Lenyeletse Maswabi; Jan Molinsky; Filipp Savvulidi; Tomas Zikmund; Dana Prukova; Diana Tuskova; Magdalena Klanova; Petra Vockova; Lucie Lateckova; Ludek Sefc; Jan Zivny; Marek Trneny; Pavel Klener
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

3.  Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells.

Authors:  Fang Dong; Haitao Bai; Xiaofang Wang; Shanshan Zhang; Zhao Wang; Miner Xie; Sen Zhang; Jinhong Wang; Sha Hao; Tao Cheng; Hideo Ema
Journal:  Blood Adv       Date:  2019-02-12

4.  The regulation of normal and leukemic hematopoietic stem cells by niches.

Authors:  Meng-Meng Huang; Jiang Zhu
Journal:  Cancer Microenviron       Date:  2012-07-22

Review 5.  The bone marrow microenvironment and leukemia: biology and therapeutic targeting.

Authors:  Edward Allan R Sison; Patrick Brown
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

6.  Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cells.

Authors:  Robert S Welner; Giovanni Amabile; Deepak Bararia; Akos Czibere; Henry Yang; Hong Zhang; Lorena Lobo De Figueiredo Pontes; Min Ye; Elena Levantini; Annalisa Di Ruscio; Giovanni Martinelli; Daniel G Tenen
Journal:  Cancer Cell       Date:  2015-05-11       Impact factor: 31.743

7.  Leukemic marrow infiltration reveals a novel role for Egr3 as a potent inhibitor of normal hematopoietic stem cell proliferation.

Authors:  Hui Cheng; Sha Hao; Yanfeng Liu; Yakun Pang; Shihui Ma; Fang Dong; Jing Xu; Guoguang Zheng; Shaoguang Li; Weiping Yuan; Tao Cheng
Journal:  Blood       Date:  2015-07-17       Impact factor: 22.113

8.  Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells.

Authors:  Chen Glait-Santar; Ronan Desmond; Xingmin Feng; Taha Bat; Jichun Chen; Elisabeth Heuston; Benjamin Mizukawa; James C Mulloy; David M Bodine; Andre Larochelle; Cynthia E Dunbar
Journal:  Stem Cells       Date:  2015-10-05       Impact factor: 6.277

9.  Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment.

Authors:  Chen Tian; Guoguang Zheng; Zhipan Cao; Qiao Li; Zhenyu Ju; Jinhong Wang; Weiping Yuan; Tao Cheng
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

10.  Altered mesenchymal niche cells impede generation of normal hematopoietic progenitor cells in leukemic bone marrow.

Authors:  M Lim; Y Pang; S Ma; S Hao; H Shi; Y Zheng; C Hua; X Gu; F Yang; W Yuan; T Cheng
Journal:  Leukemia       Date:  2015-08-04       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.